Clinical and Translational Radiation Oncology

Slides:

Advertisements

Similar presentations

A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases Vithusha Ganesh, Stephanie.

Advertisements

Fig. 1 Frequency distribution of initial palliative treatment modalities used. EBRT, external beam radiotherapy. Initial palliative treatment modality.

A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy

Su K. Metcalfe, MD, MPH, Michael T

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.

miR p Is a Novel Prognostic Biomarker of Prostate Cancer

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy Lisette.

Critical Reviews in Oncology / Hematology

PUBLISH ONLY Journal of Thoracic Oncology

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

Anxiety After Diagnosis Predicts Lung Cancer–Specific and Overall Survival in Patients With Stage III Non–Small Cell Lung Cancer: A Population-Based Cohort.

Volume 71, Issue 5, Pages (May 2017)

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With.

Volume 72, Issue 5, Pages (November 2017)

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma M. Ashton, N. O'Rourke, N.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

European Urology Oncology

Clinical and Translational Radiation Oncology

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 71, Issue 5, Pages (May 2017)

Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases Edward Chow, MBBS, Lori Davis, PhD, Lori Holden,

Brenda G. Clark, PhD, Robert J

Pain in cancer survivors; filling in the gaps

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base Amy C. Moreno,

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer

Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer Frank J. Lagerwaard, MD, PhD, Neil K. Aaronson,

Clinical and Translational Radiation Oncology

Frank Detterbeck, MD Journal of Thoracic Oncology

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Changes in apparent diffusion coefficient radiomics features during dose-painted radiotherapy and high dose rate brachytherapy for prostate cancer Sangjune.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Clinical and Translational Radiation Oncology

Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: Prognostic Factors and.

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer Sweet Ping.

Survival and failure types after radiation therapy of vulvar cancer

Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy Cédric Chevalier,

Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy A. van.

Jean-Emmanuel Bibault, Ingeborg Tinhofer

PUBLISH ONLY Journal of Thoracic Oncology

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor.

U.S. Hospice Benefits Journal of Pain and Symptom Management

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.

Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer Elaine Y.L. Leung, MB ChB,

Management of Prostate Cancer: Global Strategies

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy Rebecca Bütof, Calogero Gumina, Chiara Valentini, Antje.

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas Debra Nana Yeboa, James B. Yu,

Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction Elizabeth Hamilton, Ellie Van Veldhuizen,

Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

Aisling Krishnan, Yat Man Tsang, Adéle Stewart-Lord

Technical Innovations and Patient Support in Radiation Oncology

Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists Jennifer Strijbos,

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Peter de Boer, Stefano Mandija, Anita M

Clinical and Translational Radiation Oncology

Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short-

Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD

Presentation transcript:

Clinical and Translational Radiation Oncology Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer Natasja R. Walterbos, Marta Fiocco, Karen J. Neelis, Yvette M. van der Linden, Alexandra M.J. Langers, Marije Slingerland, Wobbe O. de Steur, Femke P. Peters, Irene M. Lips Clinical and Translational Radiation Oncology Volume 17, Pages 24-31 (July 2019) DOI: 10.1016/j.ctro.2019.04.017 Copyright © 2019 The Authors Terms and Conditions

Fig. 1 Overall survival by EBRT treatment schedules. Clinical and Translational Radiation Oncology 2019 17, 24-31DOI: (10.1016/j.ctro.2019.04.017) Copyright © 2019 The Authors Terms and Conditions

Fig. 2 Estimated overall survival by prognostic variables; Karnofsky performance status (KPS), current presentation, tumour length and distant metastasis present at baseline (M stage). Clinical and Translational Radiation Oncology 2019 17, 24-31DOI: (10.1016/j.ctro.2019.04.017) Copyright © 2019 The Authors Terms and Conditions

Fig. 3 Cumulative incidence of second intervention after palliative EBRT in patients with esophageal cancer. Clinical and Translational Radiation Oncology 2019 17, 24-31DOI: (10.1016/j.ctro.2019.04.017) Copyright © 2019 The Authors Terms and Conditions